Data / Form D filings / Portal Biotechnologies, Inc.
Portal Biotechnologies, Inc.: Form D filings
Portal Biotechnologies, Inc., a biotechnology company in Arlington, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on May 29, 2026, reports $9 million sold of a $9 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 BRUNSWICK RD., Arlington, MA, 02476
- Phone
- (415) 233-3357
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2049466
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | New notice | $8,999,999 | $8,999,999 | 12 | May 15, 2026 | sec.gov | |
| May 29, 2026 | Amendment | $11,905,000 | $11,694,998 | $210,002 | 43 | Dec 11, 2024 | sec.gov |
| Dec 26, 2024 | New notice | $11,905,000 | $11,694,998 | $210,002 | 43 | Dec 11, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Armon Sharei | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 25, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Portal Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.